4127.TWO Tien Liang BioTech Co., Ltd.

Healthcare Drug Manufacturers - Specialty & Generic Taiwan OTC Exchange
33.05 TWD
Close of Nov 6, 2026
29.00 96.00
Market cap
TWD 1.51B
P/E
21.7x
P/B
3.06x
ROE
18.6%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 4127.TWO undervalued?

Graham number
Price33.05
Graham value19.23
Premium71.9%

4127.TWO trades 71.9% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Tien Liang BioTech Co., Ltd. fundamental analysis

No fundamental analysis for Tien Liang BioTech Co., Ltd. yet.

Tien Liang BioTech Co., Ltd. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Tien Liang BioTech Co., Ltd.

Tien Liang BioTech Co., Ltd. manufactures and sells pharmaceutical products in Taiwan. The company offers Chinese and Western medicine, other healthcare, and cosmetic products through online and offline channels. Tien Liang BioTech Co., Ltd. was founded in 1971 and is based in New Taipei City, Taiwan.

Full company profile